Abstract
Accurate and competent assessment of the spectrum of disorders of consciousness, and an understanding of the neuroanatomical and neurophysiological mechanisms underlying them, is crucial for guiding treatment plans and prognostication. This chapter describes the various presentations seen in disorders of consciousness; the anatomical and physiological foundations of arousal failure; the clinical approach to a patient presenting with acute coma; treatments in acute and chronic coma; and the approach to a patient with suspected brain death. Impairments of consciousness are manifested by spectrum of clinical syndromes ranging from encephalopathy to coma. They are the final pathway for a broad range of diseases that share the common thread of pathophysiological derangement of the pons, midbrain, and thalamus or simultaneous damage to bilateral thalamocortical projections or bilateral cortices. Encephalopathy is an impairment of normal arousal in which the level of arousal fluctuates. Minimally conscious state is a syndrome where the patient is awake but in which there is only evidence of a minimal awareness of self or environment. Akinetic mutism is a rare form of arousal failure, characterized by an emotionless, frequently motionless state with intact visual tracking, and occurs commonly due to lesions in the bilateral anterior cingulate gyri. Unresponsive wakefulness syndrome, a new name for the previously described persistent vegetative state, is a syndrome where patients are awake (eyes open) but remain otherwise unresponsive, showing only reflexive movements. Coma is a state of complete unresponsiveness to external and internal stimuli, typified by a complete failure of normal arousal. Finally, brain death is defined as the irreversible cessation of clinical brain activity. Clinicians must take care to rule out mimics such as the locked-in syndrome and covert consciousness. In locked-in syndrome, patients have intact arousal and awareness but can only communicate through blinking and/or upward gaze due to severe injury in the ventral pons. Recent studies using EEG have also shown evidence of brain activation to commands in otherwise unresponsive patients, suggesting that there are patients with covert consciousness that don’t have the ability to communicate at all.
Physicians must be able to recognize these syndromes, as well as neurological emergencies associated with them. As needed, prompt application of advance cardiac life support (ACLS) and emergency neurological life support (ENLS) algorithms could dramatically impact the course of someone presenting with acute coma. Cerebral herniation associated with a comatose state may require the initiation of a brain code and administration of emergent therapies to decrease ICP including appropriate head of the bed and neck positioning; placement of central access as needed; controlled hyperventilation; and use of hypertonic saline or mannitol. For patients in coma over a longer period of time, new therapies are emerging and being investigated to stimulate patients and maximize their improvement.
The final section of this chapter discusses the diagnosis of brain death. It includes criteria and guidance for the clinical exams involved, and an overview of the various ancillary tests that can be done. It also discusses special considerations for patients undergoing targeted temperature management or on extracorporeal membrane oxygenation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Posner JB, Plum F. Plum and Posner’s diagnosis of stupor and coma. 4th ed. Oxford: Oxford University Press; 2007.
Laureys S, Celesia GG, Cohadon F, et al. Unresponsive wakefulness syndrome: a new name for the vegetative state or apallic syndrome. BMC Med. 2010;8:68.
Giacino S, Ashwal N, Childs R, Cranford B, Jennett DI, Katz JP, Kelly JH, Rosenberg J, Whyte RD, et al. The minimally conscious state. Neurology. 2002;58(3):349–53.
Thibaut A, Bodien YG, Laureys S, Giacino JT. Minimally conscious state “plus”: diagnostic criteria and relation to functional recovery. J Neurol. 2020;267:1245–54.
Owen AM, Coleman MR, Boly M, Davis MH, Laureys S, Pickard JD. Detecting awareness in the vegetative state. Science. 2006;313:1402.
Monti MM, Vanhaudenhuyse A, Coleman MR, Boly M, Pickard JD, Tshibanda L, et al. Willful modulation of brain activity in disorders of consciousness. N Engl J Med. 2010;362:579–89.
Edlow BL, Claassen J, Schiff ND, Greer DM. Recovery from disorders of consciousness: mechanisms, prognosis and emerging therapies. Nat Rev Neurol. 2020;14:1–22.
Claasen J, Doyle K, Matory Am Couch C, et al. Detection of brain activation in unresponsive patients with acute brain injury. N Engl J Med. 2019;380:2497–505.
Steriade M. Corticothalamic resonance, states of vigilance and mentation. Neuroscience. 2000;101(2):243–76.
Llinas RR, Steriade M. Bursting of thalamic neurons and states of vigilance. J Neurophysiol. 2006;95(6):3297–308.
Hoesch RE, Koenig MA, Geocadin RG. Coma after global ischemic brain injury: pathophysiology and emerging therapies. Crit Care Clin. 2008;24(1):25–44. vii–viii
Lindsley DB, Schreiner LH, Knowles WB, Magoun HW. Behavioral and EEG changes following chronic brain stem lesions in the cat. Electroencephalogr Clin Neurophysiol. 1950;2(4):483–98.
Jones BE. Arousal systems. Front Biosci. 2003;8:s438–51.
Starzl TE, Taylor CW, Magoun HW. Ascending conduction in reticular activating system, with special reference to the diencephalon. J Neurophysiol. 1951;14(6):461–77.
Steriade M, Oakson G, Ropert N. Firing rates and patterns of midbrain reticular neurons during steady and transitional states of the sleep-waking cycle. Exp Brain Res. 1982;46(1):37–51.
Jones EG. Thalamic circuitry and thalamocortical synchrony. Philos Trans R Soc Lond Ser B Biol Sci. 2002;357(1428):1659–73.
Groenewegen HJ, Berendse HW. The specificity of the ‘nonspecific’ midline and intralaminar thalamic nuclei. Trends Neurosci. 1994;17(2):52–7.
Lin JS, Sakai K, Vanni-Mercier G, Jouvet M. A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res. 1989;479(2):225–40.
Panula P, Yang HY, Costa E. Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci U S A. 1984;81(8):2572–6.
Jin CY, Kalimo H, Panula P. The histaminergic system in human thalamus: correlation of innervation to receptor expression. Eur J Neurosci. 2002;15(7):1125–38.
Alexandre C, Andermann ML, Scammell TE. Control of arousal by the orexin neurons. Curr Opin Neurobiol. 2013;23(5):752–9.
Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 1998;18:9996–10015.
Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature. 2005;437:1257–63.
Rye DB, Wainer BH, Mesulam MM, Mufson EJ, Saper CB. Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase. Neuroscience. 1984;13(3):627–43.
Buzsaki G, Bickford RG, Ponomareff G, Thal LJ, Mandel R, Gage FH. Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci. 1988;8(11):4007–26.
Szymusiak R, McGinty D. Sleep-related neuronal discharge in the basal forebrain of cats. Brain Res. 1986;370(1):82–92.
Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334(8):494–500.
McKinney AM, Jagadeesan BD, Truwit CL. Central-variant posterior reversible encephalopathy syndrome: brainstem or basal ganglia involvement lacking cortical or subcortical cerebral edema. AJR Am J Roentgenol. 2013;201:631–8.
Hinduja A. Posterior reversible encephalopathy syndrome: clinical features and outcome. Front Neurol. 2020;11:71.
Ishii M. Endocrine emergencies with neurological manifestations. Continuum (Minneap Minn). 2017;23(3):778–801.
Krause M, Hocker S. Toxin-induced coma and central nervous system depression. Neurol Clin. 2020;38(4):825–41.
McNicoll L, Pisani MA, Zhang Y, Ely EW, Siegel MD, Inouye SK. Delirium in the intensive care unit: occurrence and clinical course in older patients. J Am Geriatr Soc. 2003;51(5):591–8.
Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Oschsner J. 2013;13(4):533–40.
Oruch R, Pryme IF, Engelsen BA, Lund A. Neuroleptic malignant syndrome; an easily overlooked medical emergency. Neuropsychiatr Dis Treat. 2017;13:161–75.
Venkatasubramanian C, Lopez GA, O’Phelan KH, et al. Emergency neurological life support: fourth edition, updates in the approach to early management of a neurological emergency. Neurocrit Care. 2020;32:636–40.
Fodstad H, Kelly PJ, Buchfelder M. History of the cushing reflex. Neurosurgery. 2006;59(5):1132–7. discussion 1137
Wijdicks EF, Bamlet WR, Maramattom BV, Manno EM, McClelland RL. Validation of a new coma scale: the FOUR score. Ann Neurol. 2005;58(4):585–93.
Iyer VN, Mandrekar JN, Danielson RD, Zubkov AY, Elmer JL, Wijdicks EF. Validity of the FOUR score coma scale in the medical intensive care unit. Mayo Clin Proc. 2009;84:694–701.
Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, INTERACT2 Investigators, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355–65.
Hemphill JC, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2032–60.
Farrokh S, Cho SM, Lefebvre AT, Zink EK, Schiavi A, Puttgen HA. Use of intraosseous hypertonic saline in critically ill patients. J Vasc Access. 2019;20(4):427–32.
Qureshi AI, Geocadin RG, Suarez JI, Ulatowski JA. Long-term outcome after medical reversal of transtentorial herniation in patients with supratentorial mass lesions. Crit Care Med. 2000;28(5):1556–64.
Koenig MA, Bryan M, Lewin JL, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70(13):1023–9.
Brazis PW, Masdeu JC, Biller J. Localization in clinical neurology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007.
Liu GT, Ronthal M. Reflex blink to visual threat. J Clin Neuroophthalmol. 1992;12(1):47–56.
Baloh RW, Yee RD, Honrubia V. Optokinetic nystagmus and parietal lobe lesions. Ann Neurol. 1980;7(3):269–76.
Geocadin RG, Callaway CW, Fink EL, Golan E, Greer DM, Ko NU, Lang E, Licht DJ, Marino BS, McNair ND, Peberdy MA, Perman SM, Sims DB, Soar J, Sandroni C, American Heart Association Emergency Cardiovascular Care Committee. Standards for studies of neurological prognostication in comatose survivors of cardiac arrest: a scientific statement from the American Heart Association. Circulation. 2019;140(9):e517–42.
Giacino JT, Kalmar K, White J. The JFK coma recovery scale – revised: measurement characteristics and diagnostic utility. Arch Phys Med Rehabil. 2004;85(12):2020–9.
Thibaut A, Schiff N, Giacino J, Laureys S, Gosseries O. Therapeutic interventions in patients with prolonged disorders of consciousness. Lancet Neurol. 2019;18:600–14.
Giacino JT, Katz D, Schiff N, et al. Practice guideline update recommendations summary: disorders of consciousness. Neurology. 2018;91:450–60.
Giacino JT, Whyte J, Bagiella E, Kalmar K, Childs N, Khademi A, Eifert B, Long D, Katz DI, Cho S, Yablon SA, Luther M, Hammond FM, Nordenbo A, Novak P, Mercer W, Maurer-Karattup P, Sherer M. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med. 2012;366:819–26.
Schnakers C, Hustinx R, Vandewalle G, et al. Measuring the effect of amantadine in chronic anoxic minimally conscious state. J Neurol Neurosurg Psychiatry. 2008;79:225–7.
Estraneo A, Pascarella A, Moretta P, Loreto V, Trojano L. Clinical and electroencephalographic on–off effect of amantadine in chronic non-traumatic minimally conscious state. J Neurol. 2015;262:1584–6.
Herrold AA, Pape TLB, Guernon A, Mallinson T, Collins E, Jordan N. Prescribing multiple neurostimulants during rehabilitation for severe brain injury. Sci World J. 2014;2014:964578.
Gosseries O, Charland-Verville V, Thonnard M, Bodart O, Laureys S, Demertzi A. Amantadine, apomorphine and zolpidem in the treatment of disorders of consciousness. Curr Pharm Des. 2014;20:4167–84.
Fridman EA, Calvar J, Bonetto M, Gamzu E, Krimchansky BZ, Meli F, et al. Fast awakening from minimally conscious state with apomorphine. Brain Inj. 2009;23:172–7.
Fridman EA, Krimchansky BZ, Bonetto M, Galperin T, Gamzu ER, Leiguarda RC, et al. Continuous subcutaneous apomorphine for severe disorders of consciousness after traumatic brain injury. Brain Inj. 2010;24:636–461.
Margetis K, Korfias SI, Gatzonis S, et al. Intrathecal baclofen associated with improvement of consciousness disorders in spasticity patients. Neuromodulation. 2014;17:699–704.
Whyte J, Rajan R, Rosenbaum A, et al. Zolpidem and restoration of consciousness. Am J Phys Med Rehabil. 2014;93:101–13.
Machado C, Estevez M, Rodriguez R, et al. Zolpidem arousing effect in persistent vegetative state patients: autonomic, EEG and behavioral assessment. Curr Pharm Des. 2014;20:4185–202.
Calabrò RS, Aricò I, De Salvo S, Conti-Nibali V, Bramanti P. Transient awakening from vegetative state: is high-dose zolpidem more effective? Psychiatry Clin Neurosci. 2015;69:122–3.
Thonnard M, Gosseries O, Demertzi A, et al. Effect of zolpidem in chronic disorders of consciousness: a prospective open-label study. Funct Neurol. 2014;28:259–64.
Williams ST, Conte MM, Goldfine AM, et al. Common resting brain dynamics indicate a possible mechanism underlying zolpidem response in severe brain injury. elife. 2013;2:e01157.
Scott G, Carhart-Harris RL. Psychedelics as a treatment for disorders of consciousness. Neurosci Conscious. 2019;2019:niz003.
Varley TF, Carhart-Harris R, Roseman L, Menon DK, Stamatakis EA. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains. NeuroImage. 2020;220:117049. https://doi.org/10.1016/j.neuroimage.2020.117049.
Thibaut A, Bruno M-A, Ledoux D, Demertzi A, Laureys S. tDCS in patients with disorders of consciousness: sham-controlled randomized double-blind study. Neurology. 2014;82:1112–8.
Pape TL-B, Rosenow JM, Harton B, et al. Preliminary framework for Familiar Auditory Sensory Training (FAST) provided during coma recovery. J Rehabil Res Dev. 2012;49:1137.
Mollaret P, Goulon M. Le coma depasse. Rev Neurol (Paris). 1959;101:3–15.
A definition of irreversible coma: report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. JAMA. 1968;205:337–40.
President’s Commission for the Study of Ethical Problems in Medicine and Biomedical Behavioral Research. Defining Death: A Report on the Medical, Legal and Ethical Issues in the Determination of Death. President’s Council on Bioethics; 1981.
The Quality Standards Subcommittee of the American Academy of Neurology. Practice parameters for determining brain death in adults (summary statement). Neurology. 1995;45(5):1012–4.
Wijdicks EFM, Varelas PN, Gronseth GS, Greer DM. Evidence-based guideline update: determining brain death in adults—report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2010;74(23):1911–8.
Greer DM, Varelas PN, Haque S, Wijdicks EFM. Variability of brain death determination guidelines in leading US neurologic institutions. Neurology. 2008;70(4):284–9.
Greer DM, Shemie SD, Lewis A, Torrance S, Varelas P, Goldenberg FD, Bernat JL, Souter M, Topcuoglu MA, Alexandrov AW, Baldisseri M, Bleck T, Citerio G, Dawson R, Hoppe A, Jacobe S, Manara A, Nakagawa TA, Pope TM, Silvester W, Thomson D, Al Rahma H, Badenes R, Baker AJ, Cerny V, Chang C, Chang TR, Gnedovskaya E, Han MK, Honeybul S, Jimenez E, Kuroda Y, Liu G, Mallick UK, Marquevich V, Mejia-Mantilla J, Piradov M, Quayyum S, Shrestha GS, Su YY, Timmons SD, Teitelbaum J, Videtta W, Zirpe K, Sung G. Determination of brain death/death by neurologic criteria: the world brain death project. JAMA. 2020;324:1078–97.
Lewis A, Bakkar A, Kreiger-Benson E, Kumpfbeck A, Liebman J, Shemie SD, Sung G, Torrance S, Greer D. Determination of death by neurologic criteria around the world. Neurology. 2020;95:e299–309.
Machado C. Brain death: a reappraisal. New York: Springer Science+Business Media, LLC; 2007.
Machado C. Jahi McMath: a new state of disorder of consciousness. J Neurosurg Sci. 2021;65(2):211–3.
Walter U, Fernandez-Torre JL, Kirschstein T, Laureys S. When is "brainstem death" brain death? The case for ancillary testing in primary infratentorial brain lesion. Clin Neurophysiol. 2018;129:2451–65.
Machado C. Multimodality evoked potentials and electroretinography in a test battery for an early diagnosis of brain death. J Neurosurg Sci. 1993;37:125–31.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mathur, R., Balucani, C., Elmashala, A., Geocadin, R. (2021). Coma, Disorders of Consciousness, and Brain Death. In: Roos, K.L. (eds) Emergency Neurology. Springer, Cham. https://doi.org/10.1007/978-3-030-75778-6_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-75778-6_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-75777-9
Online ISBN: 978-3-030-75778-6
eBook Packages: MedicineMedicine (R0)